Research Notes: How Tysabri triggers Progressive Multifocal Leukoencephalopathy: pathophysiology

A curated reading list of authoritative medical research, drug-safety databases, and focused analysis for researchers, patients, and advocates.

Featured analysis

How Tysabri triggers Progressive Multifocal Leukoencephalopathy: pathophysiology — Research Summary

A focused review of background, context, and source material on this subject.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.